Vol. 9 No. 2 (2020)

Published: 2020-06-18

Editor’s Page

Appeal of Editor-in-Chief

D.D. Ivanov

85
- PDF (Українська)

The Gallery

Professor A.I. Gozhenko

D.D. Ivanov

86
- PDF (Українська)

Original Articles

Priority of cystatin C among other renal biomarkers for pre-eclampsia diagnosing

V.G. Marichereda, M.Yu. Holubenko, L.I. Berlinska

87-91
- PDF (Українська)
Kidneys and autonomic dysfunction in children and adolescents (part I)

L.I. Vakulenko

92-98
- PDF
10-year personal experience of rituximab use in nephrological patients

D.D. Ivanov, O.O. Dyadyk, S.O. Rotova, M.D. Ivanovа

99-104
- PDF (Українська)

Reviews

Comparative analysis of recommendations for the management of patients with ANCA-associated vasculitis and kidney damage

I.Yu. Golovach, Ye.D. Yehudina

105-116
- PDF (Русский)

Guidelines

Management of patients on dialysis and with kidney transplant during COVID-19 coronavirus infection

Federico Alberici, Elisa Delbarba, Chiara Manenti, Laura Econimo, Francesca Valerio, Alessandra Pola, Camilla Maffei, Stefano Possenti, Paola Gaggia, Ezio Movilli, Sergio Bove, Fabio Malberti, Marco Farina, Martina Bracchi, Ester Maria Costantino, Nicola Bossini, Mario Gaggiotti, Francesco Scolari

117-120
- PDF (Українська)
- PDF
2019 Update of the Joint European League Against Rheumatism and European Renal Association — European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis

No authors

121-125
- PDF
- PDF (Українська)

Clinical Observation

A case of the secondary AA amyloidosis in Bekhterev’s disease: a successful 3-year therapy with adalimumab

D.D. Ivanov, O.H. Fedorenko, O.O. Dyadik

126-132
- PDF (Русский)